Early Science, Exciting Questions: What a New Preprint Study Suggests About Spermidine and Liver Health

At Oxford Healthspan, one of our commitments to you is to share the science as it unfolds, not just once it's been neatly packaged for public consumption. So when a compelling new preprint exploring spermidine's potential role in liver health landed on our radar, we felt it was worth bringing to you directly [1].

For transparency: this manuscript has not yet completed the full peer review process, meaning the findings are preliminary. We share it in that spirit, as a window into where the science may be heading.

The study set out to explore whether spermidine might support the health of specialized liver cells called liver sinusoidal endothelial cells (or LSECs). Think of these as the liver's internal gatekeepers. In a well-functioning liver, they regulate the surrounding tissue, keeping it pliable and helping to prevent fibrosis, the gradual process by which healthy tissue is replaced by scar tissue.

In both cell culture and animal models, the researchers observed that spermidine appeared to preserve LSEC function and slow fibrosis progression. If these findings hold through further scrutiny, they would represent a meaningful addition to our understanding of spermidine's reach within the body.

The proposed mechanism

Spermidine appears to activate a cellular regulator called NRF2, which may increase the activity of a protein called UBE2G2. This protein is thought to tag a molecule called biglycan for breakdown. The researchers observed that when biglycan accumulated, it disrupted healthy signaling between liver cell types and accelerated changes that compromise LSEC (the liver's internal gatekeepers) functioning.

By potentially facilitating biglycan clearance, spermidine may help restore more normal cellular communication within liver tissue. These are early-stage mechanistic findings, and further research will be needed to confirm whether the same processes operate in humans in the same way. However, this reveals an intriguing avenue of research as to spermidine's potential role in liver health.

What the population data suggests

The researchers also analyzed dietary data from NHANES, a large ongoing American health and nutrition study, and found an association between higher dietary spermidine intake and lower rates of liver fibrosis. While it is a useful signal, association does not establish causation. Many factors influence liver health, and this analysis, like the broader study, awaits full peer review.

Why we're paying attention

The liver is one of the body's most metabolically active organs, central to detoxification, hormone regulation, and nutrient processing [2]. Research exploring how to support liver health at a cellular level is exactly the kind of science we believe deserves a wider audience.

The science around spermidine continues to develop, and not every study arrives fully formed. Some of the most exciting discoveries begin precisely here: as early signals that prompt deeper investigation. We'll be watching this one closely, and we'll keep you informed as the research evolves.

This article discusses a preprint manuscript that has not yet completed full peer review. Findings are preliminary and subject to change. This content is for educational purposes only and does not constitute medical advice. Primeadine is a dietary supplement, not a treatment for liver disease or any other medical condition. Please consult your healthcare provider with any questions about your health.

References: 

[1] Zeng, C., Liu, J., Jin, Z. et al. Spermidine suppresses liver fibrosis by remodeling the communication signal between liver sinusoidal endothelial cells and hepatic stellate cells.Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03129-4

[2] Kalra A, Yetiskul E, Wehrle CJ, et al. Physiology, Liver. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535438/